Anzahl der Einträge: 23.
Artikel
Fischbach, Claudia,
Spruß, Thilo,
Weiser, Barbara,
Neubauer, M.,
Becker, Christian,
Hacker, Michael,
Göpferich, Achim und
Blunk, Torsten
(2004)
Generation of mature fat pads in vitro and in vivo utilizing 3-D long-term culture of 3T3-L1 preadipocytes.
Experimental Cell Research 300 (1), S. 54-64.
Volltext nicht vorhanden.
Schertl, Sabine,
Hartmann, Rolf W.,
Batzl-Hartmann, Christine,
Bernhardt, Günther,
Spruß, Thilo,
Beckenlehner, Karin,
Koch, Marion,
Krauser, Rudolf,
Schlemmer, Richard,
Gust, Ronald und
Schönenberger, Helmut
(2004)
[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) complexes, compounds for the endocrine therapy of breast cancer - mode of action I: antitumor activity due to the reduction of the endogenous estrogen level.
Archiv der Pharmazie 337 (6), S. 335-348.
Volltext nicht vorhanden.
Vogelhuber, Werner,
Spruß, Thilo,
Bernhardt, Günther,
Buschauer, Armin und
Göpferich, Achim
(2002)
Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenografts,.
International Journal of Pharmaceutics 238 (1-2), S. 111-121.
Volltext nicht vorhanden.
Fellner, Stephan,
Bauer, Björn,
Miller, David S.,
Schaffrick, Martina,
Fankhänel, Martina,
Spruß, Thilo,
Bernhardt, Günther,
Graeff, Claudia,
Färber, Lothar,
Gschaidmeier, Harald,
Buschauer, Armin und
Fricker, Gert
(2002)
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo.
The Journal of Clinical Investigation 110 (9), S. 1309-1318.
Schertl, Sabine,
Hartmann, Rolf W.,
Batzl-Hartmann, Christine,
Schlemmer, Richard,
Spruß, Thilo,
Bernhardt, Günther,
Gust, Ronald und
Schönenberger, Helmut
(2001)
1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.
Archiv der Pharmazie 334 (4), S. 125-137.
Volltext nicht vorhanden.
Schlemmer, Richard,
Spruß, Thilo,
Bernhardt, Günther und
Schönenberger, Helmut
(2001)
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound.
Archiv der Pharmazie 334 (10), S. 309-317.
Volltext nicht vorhanden.
Schlemmer, Richard,
Spruß, Thilo,
Bernhardt, Günther und
Schönenberger, Helmut
(2000)
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloro-platinum(II) act as an immune response modifier? Part III: Progressively growing MXT-M-3,2 breast cancer stimulates the proliferation of phagocytes in B6D2F1 mice.
Archiv der Pharmazie 333 (12), S. 404-414.
Volltext nicht vorhanden.
Schlemmer, Richard,
Spruß, Thilo,
Bernhardt, Günther und
Schönenberger, Helmut
(2000)
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part 1: The MXT-M-3.2 breast cancer stimulates the growth of an identical second graft; [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplat inum (II) inhibits this process.
Archiv der Pharmazie 333 (2-3), S. 69-71.
Volltext nicht vorhanden.
Schlemmer, Richard,
Spruß, Thilo,
Bernhardt, Günther und
Schönenberger, Helmut
(2000)
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) on the specific immune defense in MXT-M-3,2 breast cancer bearing mice.
Archiv der Pharmazie 333 (12), S. 397-403.
Volltext nicht vorhanden.
Schlemmer, Richard,
Spruß, Thilo,
Bernhardt, Günther und
Schönenberger, Helmut
(1999)
[meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl) ethylenediamine]dichloroplatinum(II), a compound with a specific activity on hormone-sensitive breast cancers--evidence for a diethylstilbestrol-like mode of action.
Archiv der Pharmazie 332 (2), S. 59-69.
Volltext nicht vorhanden.
Bernhardt, Günther,
Gust, Ronald,
Reile, Herta,
vom Orde, Hans Dieter,
Müller, Richard,
Keller, Christoph,
Spruß, Thilo,
Schönenberger, Helmut,
Burgemeister, Thomas,
Mannschreck, Albrecht,
Range, Klaus-Jürgen und
Klement, Ulrich
(1992)
[1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. II. Synthesis and preliminary testing of the enantiomeric complexes.
Journal of cancer research and clinical oncology 118 (3), S. 201-208.
Bernhardt, Günther,
Gust, Ronald,
Reile, Herta,
vom Orde, Hans Dieter,
Müller, Richard,
Keller, Christoph,
Spruß, Thilo,
Schönenberger, Helmut,
Burgemeister, Thomas,
Mannschreck, Albrecht,
Range, Klaus Jürgen und
Klement, Ulrich
(1992)
[1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. III. Detailed evaluation of the antitumor activity of the enantiomeric complexes on the human NIH:OVCAR-3 ovarian cancer cell line.
Journal of cancer research and clinical oncology 118 (3), S. 209-215.
Reile, Herta,
Spruß, Thilo,
Bernhardt, Günther,
Müller, Richard,
Gust, Ronald und
Schönenberger, Helmut
(1991)
Tumor inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes. Part IV: Biological evaluation--in vivo studies on the P 388 leukemia.
Archiv der Pharmazie 324 (7), S. 405-409.
Reile, Herta,
Spruß, Thilo,
Müller, Richard,
Gust, Ronald,
Bernhardt, Günther,
Schönenberger, Helmut und
Engel, Jürgen
(1990)
Tumor inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes, III: Evaluation of the mammary tumor inhibiting properties.
Archiv der Pharmazie 323 (5), S. 301-306.
vom Orde, Hans Dieter,
Reile, Herta,
Müller, Richard,
Gust, Ronald,
Bernhardt, Günther,
Spruß, Thilo,
Schönenberger, Helmut,
Burgemeister, Thomas und
Mannschreck, Albrecht
(1990)
Tumor-inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes. V. Synthesis and evaluation of enantiomeric [1,2-bis-(4-fluorophenyl)ethylenediamine]dichloroplatinum(II) complexes.
Journal of cancer research and clinical oncology 116 (5), S. 434-438.
Diese Liste wurde erzeugt am Thu Sep 26 04:07:20 2024 CEST.